A Chinese clam exporter has been pulled up by the United State’s Food and Drug Administration (FDA) for shortcomings in its hygiene system.
Dandong Shenghai Foodstuffs got a letter recently from the FDA informing it of “serious violations” in its Hazard Analysis & Critical Control Point (HACCP) procedures detected during a May inspection by FDA officials of the Shenghai factory located in Donggang, near the North Korean border in northern China.
The problems relate to FDA concerns over the post-cooking cooling process used by Shenghai.
A response from the company to an FDA letter after the May inspection was deemed “not adequate” and Shenghai now has a fortnight to outline a fix to the problems.
The FDA hasn’t yet blocked imports into the U.S. from Shenghai, which was set up in 2013 to process imports of salmon and other products into China. The company also exports shellfish to America, Europe, and the U.S.
Image courtesy of Dandong Shenghai Foodstuffs
